Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2041 AL 2055

Oxidative damage to RNA in aging and neurodegenerative disorders

Nunomura A, Moreira PI, Castellani RJ, Lee HG, Zhu X, Smith MA, Perry G.

Neurotox Res. 2012 Oct;22(3):231-48. doi: 10.1007/s12640-012-9331-x. Epub 2012 Jun 6.

Redox proteomics

Butterfield DA, Dalle-Donne I.

Antioxid Redox Signal. 2012 Dec 1;17(11):1487-9. doi: 10.1089/ars.2012.4742. Epub 2012 Jul 9.

Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience

Umahara T, Uchihara T, Iwamoto T.

Geriatr Gerontol Int. 2012 Oct;12(4):586-99. doi: 10.1111/j.1447-0594.2012.00860.x. Epub 2012 Jun 4.

Rehabilitation improves dyskinesias in Parkinsonian patients: a pilot study comparing two different rehabilitative treatments

Frazzitta G, Bertotti G, Morelli M, Riboldazzi G, Pelosin E, Balbi P, Boveri N, Comi C, Turla M, Leva S, Felicetti G, Maestri R.

NeuroRehabilitation. 2012;30(4):295-301. doi: 10.3233/NRE-2012-0758.

Rapid resolution of akinetic mutism in delayed post-hypoxic leukoencephalopathy with intravenous magnesium sulfate

Rozen TD.

NeuroRehabilitation. 2012;30(4):329-32. doi: 10.3233/NRE-2012-0763.

Does robotic gait training improve balance in Parkinson's disease? A randomized controlled trial

Picelli A, Melotti C, Origano F, Waldner A, Gimigliano R, Smania N.

Parkinsonism Relat Disord. 2012 Sep;18(8):990-3. doi: 10.1016/j.parkreldis.2012.05.010. Epub 2012 Jun 4.

Generation of induced pluripotent stem cells from Asian patients with chronic neurodegenerative diseases

Luo Y, Fan Y, Chen X, Yu B, Yue L, Wang D, Li Q, Chen Y, Sun X.

J Reprod Dev. 2012;58(5):515-21. doi: 10.1262/jrd.2012-059. Epub 2012 May 24.

Olfactory dysfunctions in neurodegenerative disorders

Ruan Y, Zheng XY, Zhang HL, Zhu W, Zhu J.

J Neurosci Res. 2012 Sep;90(9):1693-700. doi: 10.1002/jnr.23054. Epub 2012 Jun 5.

Characteristics of persons with overactive bladder of presumed neurologic origin: results from the Boston Area Community Health (BACH) survey

Hall SA, Curto TM, Onyenwenyi A, Lemack GE, Tennstedt SL, Link CL, McKinlay JB.

Neurourol Urodyn. 2012 Sep;31(7):1149-55. doi: 10.1002/nau.22232. Epub 2012 Jun 6.

The integral role of speech production in the science and treatment of Parkinson's disease

Ramig LA, Fox C.

Mov Disord. 2012 Jun;27(7):811-3. doi: 10.1002/mds.25046. Epub 2012 Jun 1.

Update on the development of lurasidone as a treatment for patients with acute schizophrenia

Yasui-Furukori N.

Drug Des Devel Ther. 2012;6:107-15. doi: 10.2147/DDDT.S11180. Epub 2012 May 8.

Motor control abnormalities in Parkinson's disease

Mazzoni P, Shabbott B, Cortés JC.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a009282. doi: 10.1101/cshperspect.a009282.

An approach to the continuous dopaminergic stimulation in Parkinson's disease

Schwartz M, Sabetay S.

Isr Med Assoc J. 2012 Mar;14(3):175-9.

Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects

Cutler DL, Tendolkar A, Grachev ID.

J Clin Pharm Ther. 2012 Oct;37(5):578-87. doi: 10.1111/j.1365-2710.2012.01349.x. Epub 2012 Jun 7.

Perfusion and metabolism imaging studies in Parkinson's disease

Borghammer P.

Dan Med J. 2012 Jun;59(6):B4466.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias